Cost analysis of substituting labetalol for nitroprusside.
D003365:Costs and Cost Analysis; D004471:Economics, Nursing; D005292:Ferricyanides / Q000627:therapeutic use*; D006801:Humans; D007263:Infusions, Parenteral; D007741:Labetalol / Q000627:therapeutic use*; D009599:Nitroprusside / Q000627:therapeutic use*; D010607:Pharmacy Service, Hospital / Q000191:economics; D013810:Therapeutic Equivalency
D005292:Ferricyanides; D009599:Nitroprusside; D007741:Labetalol